Dr. Lok is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1989 - 1991
- University of Hong Kong Faculty of MedicineClass of 1977
Certifications & Licensure
- MI State Medical License 1998 - 2027
- LA State Medical License 1994 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment Start of enrollment: 2000 Jun 01
- Hepatitis B Research Network Adult Cohort Study Start of enrollment: 2010 Dec 01
- Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 142 citationsHepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.Adrian M. Di Bisceglie, Andre C. Lyra, Myron Schwartz, Rajender Reddy, Paul Martin
The American Journal of Gastroenterology. 2003-09-01 - 379 citationsOutcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R. Morgan, Marc G. Ghany, Hae-Young Kim, Kristin K. Snow, Mitchell L. Shiffman
Hepatology. 2010-09-01 - 81 citationsImpact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomersMonica A. Konerman, Mary Thomson, Kristen Gray, Meghan Moore, Hetal Choxi
Hepatology. 2017-12-01
Journal Articles
- Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, ChinaAnna S Lok, Stephanie Chen, Samantha Chao, Digestive Diseases and Sciences
- Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated with Poor Patient‐Reported Outcomes in CirrhosisElliot B Tapper, Neehar D Parikh, Anna S Lok, Hepatology
Other
- Spike in Hep C Infections Mutes Thrill of Recent CureAnna Lok, MD, U-M Health System
https://www.doximity.com/articles/6ec15d6f-c828-4ef0-ab64-dbb58284003e
UpToDate, Wolters Kluwer Health - 2013-02-07 - Clinical significance and molecular characteristics of common hepatitis B virus variantsLok AS, Chu C
http://www.uptodate.com/contents/clinical-significance-and-molecular-characteristics-of-common-hepat
UpToDate, Wolters Kluwer Health - 2013-02-05 - Hepatitis D virus reinfection following liver transplantationLok AS
http://www.uptodate.com/contents/hepatitis-d-virus-reinfection-following-liver-transplantation
UpToDate, Wolters Kluwer Health - 2013-01-07 - Join now to see all
Authored Content
- Spike in Hep C Infections Mutes Thrill of Recent CureAugust 2018
Press Mentions
- No Racial Disparities Observed in Chronic HBV Treatment Rates Among Eligible PatientsApril 12th, 2023
- Five Faculty Members with Diverse Backgrounds Elected to National Academy of MedicineOctober 17th, 2022
- Then and Now: Demographics of the AGAJune 1st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: